Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication-induced oesophageal disorders.

Karl-Uwe Petersen1, Daniel Jaspersen

  • 1Institut für Pharmakologie und Toxikologie, Rheinisch-Westfälische Technische Hochschule Aachen, Wendlingweg 2, 52057 Germany. KarlUwe.Petersen@post.rwth-aachen.de

Expert Opinion on Drug Safety
|August 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfer of Intravenous Remimazolam into Milk of Lactating Sheep and Uptake by Breast-fed Lambs.

Current drug metabolism·2025
Same author

Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: <i>In-Vitro</i> Studies and Literature Review.

Current drug metabolism·2024
Same author

Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding.

Current drug metabolism·2024
Same author

The Metabolism of the New Benzodiazepine Remimazolam.

Current drug metabolism·2024
Same author

Comment on: "Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS".

Drugs in R&D·2021
Same author

The Role of Sphere Size in the Context of Pancreatin Therapy for Exocrine Pancreatic Insufficiency: A Systematic Review.

Journal of gastrointestinal and liver diseases : JGLD·2021

Medications can cause esophageal distress and injury through smooth muscle relaxation or local toxicity. Identifying and removing the offending drug, alongside proper intake, is key for prevention and treatment.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Internal Medicine

Background:

  • Medication-induced esophageal injury is a growing clinical concern.
  • Drugs can exacerbate gastro-esophageal reflux disease or cause direct esophageal damage.
  • Factors like drug formulation and patient intake methods influence risk.

Purpose of the Study:

  • To review the mechanisms and clinical relevance of drug-induced esophageal injury.
  • To highlight common offending medications and their effects.
  • To discuss diagnostic standards, treatment, and prevention strategies.

Main Methods:

  • Literature review of drug-induced esophageal conditions.
  • Categorization of drugs based on their mechanism of esophageal injury.

Related Experiment Videos

  • Discussion of diagnostic and therapeutic approaches.

    • Main Results:

    • Smooth muscle relaxants (e.g., calcium antagonists, nitrates) can worsen GERD.
    • Locally toxic drugs (e.g., alendronate, NSAIDs, antibiotics) can cause ulcers, strictures, and bleeding.
    • Drug formulation and administration (upright position, adequate fluid) significantly impact esophageal safety.

    Conclusions:

    • Drug-induced esophageal injury requires careful consideration of medication choice and intake.
    • Endoscopy is the gold standard for diagnosis.
    • Management involves drug withdrawal, supportive care, and preventative measures including re-appraising drug indications.